The effectiveness of this S-3 for a massive secondary resale creates immediate overhang risk. Traders should monitor for any selling by the institutional investors who received these shares in the April private placement. The 49.5M common warrants, if exercised, would add further dilution. Given the 93% analyst bullish consensus, any selling pressure could create a disconnect between fundamentals and price action.
Price Chart
Executive Summary
The SEC declared effective Achieve Life Sciences' S-3 registration statement (File No. 333-295798) on May 21, 2026, covering the resale of up to 99,037,138 shares of common stock by selling stockholders. This includes 49,418,069 shares, 100,500 pre-funded warrant shares, and 49,518,569 common warrant shares issued in an April 2026 private placement. The company will not receive any proceeds from the resale but may receive cash upon exercise of the warrants.
Key Facts
- Effectiveness date: May 21, 2026
- Registration covers up to 99,037,138 shares of common stock for resale by selling stockholders
- Shares originate from a securities purchase agreement dated April 15, 2026
- Company will not receive proceeds from the resale of shares
- Company may receive proceeds from cash exercise of pre-funded warrants and common warrants
- Current market cap is approximately $472M, making the registered shares a significant potential overhang
Financial Impact
Up to 99,037,138 shares registered for resale, representing a substantial portion of the company's outstanding shares relative to a $472M market cap.
Risk Factors
- Significant dilution overhang from up to 99M shares eligible for resale
- Potential near-term selling pressure from institutional investors
- Warrant exercises could further dilute existing shareholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001729 |
| Document: 9999999995-26-001729-index.html | 9999999995-26-001729 |
| Document: 9999999995-26-001729.txt | 9999999995-26-001729 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 3 | $7.24 $7.19 | ▼ −0.69% | ▼ −0.27% | $6.49 (−10.36%) |
Oct 1, 2026 25d ago | 8-K | $7.24 $7.01 | ▼ −3.18% | ▼ −3.85% | $6.49 (−10.36%) |
Aug 14, 2026 10w ago | 8-K | $7.50 $7.52 | ▼ −0.27% | ▼ −0.94% | $6.49 (+13.47%) |
Aug 11, 2026 10w ago | 8-K | $6.69 $7.25 | ▲ +8.37% | ▲ +7.67% | $6.49 (−2.99%) |
Aug 11, 2026 10w ago | Press Release | $6.77 $6.69 | ▲ +1.18% | ▲ +1.43% | $6.49 (+4.14%) |
Aug 7, 2026 11w ago | Institutional Cluster | $6.65 $6.67 | ▲ +0.30% | ▲ +0.33% | $6.49 (−2.41%) |
Jun 11, 2026 19w ago | Institutional Cluster | $5.52 $5.52 | · 0.00% | ▲ +0.54% | $6.49 (−17.57%) |
Jun 2, 2026 20w ago | 8-K | $5.03 $4.92 | ▼ −2.19% | ▼ −1.49% | $6.49 (+29.03%) |
May 22, 2026 22w ago | EFFECT | $4.69 $4.56 | ▲ +2.77% | ▲ +3.36% | $6.49 (−38.38%) |
May 19, 2026 22w ago | Press Release | $4.45 $4.57 | ▲ +2.70% | ▲ +1.66% | $6.49 (+45.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers